The S100B Protein: A Multifaceted Pathogenic Factor More Than a Biomarker
International Journal of Molecular Sciences · 31.05.2023 · 24 (11) · 9605
DOI: 10.3390/ijms24119605 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 31.05.2023. Verfasst von Fabrizio Michetti und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Catholic University of the Sacred Heart, 00168 Rome, Italy. Hauptthemen laut MEDLINE: Nervous System Diseases, Parkinson Disease, S100 Calcium Binding Protein beta Subunit. Die Arbeit wurde bisher 145-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nando and Elsa Peretti Foundation.
Abstract (Originalsprache)
S100B is a calcium-binding protein mainly concentrated in astrocytes in the nervous system. Its levels in biological fluids are recognized as a reliable biomarker of active neural distress, and more recently, mounting evidence points to S100B as a Damage-Associated Molecular Pattern molecule, which, at high concentration, triggers tissue reactions to damage. S100B levels and/or distribution in the nervous tissue of patients and/or experimental models of different neural disorders, for which the protein is used as a biomarker, are directly related to the progress of the disease. In addition, in experimental models of diseases such as Alzheimer’s and Parkinson’s diseases, amyotrophic lateral sclerosis, multiple sclerosis, traumatic and vascular acute neural injury, epilepsy, and inflammatory bowel disease, alteration of S100B levels correlates with the occurrence of clinical and/or toxic parameters. In general, overexpression/administration of S100B worsens the clinical presentation, whereas deletion/inactivation of the protein contributes to the amelioration of the symptoms. Thus, the S100B protein may be proposed as a common pathogenic factor in different disorders, sharing different symptoms and etiologies but appearing to share some common pathogenic processes reasonably attributable to neuroinflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience, Catholic University of the Sacred Heart, 00168 Rome, Italy.
- IRCCS San Raffaele Scientific Institute, Università Vita-Salute San Raffaele, 20132 Milan, Italy.
- Department of Medicine, LUM University, 70010 Casamassima, Italy.
- Genes, Via Venti Settembre 118, 00187 Roma, Italy.
- Istituto di Scienze e Tecnologie Chimiche "Giulio Natta" SCITEC-CNR, 00168 Rome, Italy.
- Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131 Padova, Italy.
ORCID-Profile: Fabrizio Michetti, Maria Elisabetta Clementi, Rosa Di Liddo, Gabriele Di Sante, Vincenzo Romano Spica
Förderung
- Nando and Elsa Peretti Foundation
Zitieren
APA
Michetti, F., Clementi, M. E., Di Liddo, R., Valeriani, F., Ria, F., Rende, M., Di Sante, G., & Romano Spica, V. (2023). The S100B Protein: A Multifaceted Pathogenic Factor More Than a Biomarker. International Journal of Molecular Sciences, 24(11), 9605. https://doi.org/10.3390/ijms24119605
Vancouver
Michetti F, Clementi ME, Di Liddo R, Valeriani F, Ria F, Rende M, et al. The S100B Protein: A Multifaceted Pathogenic Factor More Than a Biomarker. International Journal of Molecular Sciences. 2023;24(11):9605. doi:10.3390/ijms24119605
BibTeX
@article{Michetti2023,
author = {Michetti, Fabrizio and Clementi, Maria Elisabetta and Di Liddo, Rosa and Valeriani, Federica and Ria, Francesco and Rende, Mario and Di Sante, Gabriele and Romano Spica, Vincenzo},
title = {The S100B Protein: A Multifaceted Pathogenic Factor More Than a Biomarker},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {11},
pages = {9605},
doi = {10.3390/ijms24119605}
}
EUVIMED